https://centenara.com/press-releases/rejuveron-raises-75-million-in-dual-tranche-series-b-and-convertible-loan-financing-to-support-healthy-aging-and-accelerate-presence-in-the-middle-east/2023-11-06T17:11:29+00:00https://centenara.com/press-releases/second-rejuveron-company-transitions-into-clinical-stage-as-first-patient-is-dosed-in-trial-of-endogena-therapeutics-novel-regenerative-treatment-for-blindness-caused-by-retinitis-pigmentosa/2023-11-06T17:11:54+00:00https://centenara.com/press-releases/rejuveron-ceo-and-co-founder-matthias-steger-named-as-a-2022-in-vivo-rising-leader/2023-11-06T17:11:10+00:00https://centenara.com/press-releases/rejuveron-transitions-to-become-a-clinical-stage-company-as-rejuvenate-biomed-starts-ground-breaking-clinical-trial-in-age-related-muscle-wasting-disease-sarcopenia/2023-11-06T17:14:17+00:00https://centenara.com/press-releases/rejuveron-increases-to-near-majority-stake-in-endogena-through-funding-20m-to-progress-treatments-for-degenerative-diseases-of-the-eye/2023-11-06T17:36:48+00:00https://centenara.com/press-releases/rejuveron-appoints-roche-veteran-bob-silverman-as-chief-business-officer-and-opens-us-operations-in-new-york/2023-11-06T17:39:52+00:00https://centenara.com/press-releases/rejuveron-leads-eur-15-7-million-series-b-investment-in-rejuvenate-biomed-to-accelerate-clinical-development-of-its-sarcopenia-treatment-for-healthy-aging/2023-11-06T17:42:09+00:00https://centenara.com/press-releases/endogena-completes-8-million-financing-and-extends-series-a-round/2023-11-06T17:46:38+00:00https://centenara.com/press-releases/rejuveron-has-moved-to-its-new-incubator-space-in-the-bio-technopark-in-schlieren-zurich/2023-11-06T17:51:40+00:00https://centenara.com/news/global-meetup-in-zurich/2023-11-06T19:34:18+00:00https://centenara.com/news/aging-intersects-with-absolutely-every-other-aspect-of-human-experience/2023-11-06T18:43:51+00:00https://centenara.com/news/my-survival-instinct-sparked-me-to-get-into-aging-research/2023-11-06T20:00:31+00:00https://centenara.com/news/rejuveron-age-better-live-longer-symposium/2023-11-06T22:28:37+00:00https://centenara.com/news/researchers-at-rejuveron-deploy-knowledge-gained-in-nobel-prize-winning-techniques-to-crack-catalysis-conundrums/2023-11-06T22:31:35+00:00https://centenara.com/news/rejuveron-nature-preview/2023-11-06T20:45:14+00:00https://centenara.com/news/women-in-biotech-what-does-it-take-to-increase-gender-equality-in-biotech/2023-11-06T22:35:38+00:00https://centenara.com/news/forget-generations-xyz-welcome-to-generation-health/2023-11-06T21:11:09+00:00https://centenara.com/news/join-the-rejuveron-age-better-live-longer-symposium/2023-11-06T22:38:29+00:00https://centenara.com/news/make-your-research-work-scientific-freedom-with-sustainable-support/2024-10-14T17:37:11+00:00https://centenara.com/news/make-your-future-at-rejuveron-from-valves-and-pipes-to-leading-longevity-discovery/2023-11-06T21:36:36+00:00https://centenara.com/news/rejuveron-senescence-therapeutics-bringing-senescent-cells-out-of-hiding/2023-11-30T01:06:25+00:00https://centenara.com/press-releases/rejuveron-life-sciences-ag-rebrands-as-centenara-labs-ag-and-provides-latest-clinical-updates/2024-09-19T14:03:09+00:00